title: Is gemcitabine plus vinorelbine active in second-line chemotherapy of metastatic breast cancer? a single-center phase 2 study.
authors.forename: Emanuela
authors.initials: E
authors.lastname: Rossi
authors.forename: Francesco
authors.initials: F
authors.lastname: Perrone
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Labonia
authors.forename: Gabriella
authors.initials: G
authors.lastname: Landi
authors.forename: Francesco
authors.initials: F
authors.lastname: Nuzzo
authors.forename: Gerardo
authors.initials: G
authors.lastname: Amabile
authors.forename: Cesare
authors.initials: C
authors.lastname: Gridelli
authors.forename: Massimo
authors.initials: M
authors.lastname: Di Maio
authors.forename: Giuseppe
authors.initials: G
authors.lastname: D'Aiuto
authors.forename: Andrea
authors.initials: A
authors.lastname: de Matteis
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008875:Middle Aged; D016879:Salvage Therapy / Q000379:methods; D016896:Treatment Outcome; D014747:Vinblastine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D000077235:Vinorelbine; D000093542:Gemcitabine
chemical_list: D003841:Deoxycytidine; D014747:Vinblastine; D000077235:Vinorelbine; D000093542:Gemcitabine